Status:
WITHDRAWN
Impact of Cholesterol Level on Long-term Coronary Bypass Graft Patency
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Coronary Artery Disease
Bypass Graft Stenosis
Eligibility:
All Genders
18+ years
Brief Summary
This single-centre cross-sectional study aims to ascertain the impact of dyslipidemia on long-term graft patency after coronary artery bypass grafting (CABG).
Detailed Description
All consecutive patients who underwent CABG from 1st January 2007 to 31st December 2008 at the Prince of Wales Hospital were eligible for entry. Graft patency will be determined by computed tomograph...
Eligibility Criteria
Inclusion
- \- All consecutive patients on record who underwent coronary artery bypass graft surgery in 2007 and 2008
Exclusion
- Death
- Single vessel LIMA-LAD anastomosis only
- Concomitant valve and aortic procedures
- Concomitant repair of post-infarct ventricular septal rupture
- Defaulted follow-up
- Informed consent cannot be obtained
- Intermediate to high risk for contrast nephropathy, defined as estimated glomerular filtration rate less than 45 ml/min/1.73m2 or serum creatinine level \<1.5 mg/dL (based on American College of Radiology criteria for diagnostic computed tomography risk)
- Pregnancy
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2027
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05393882
Start Date
September 1 2025
End Date
December 31 2027
Last Update
March 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Hong Kong